Financials

  • Market Capitalization 9.31 B
  • Employee 253
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-23.27
Relación precio/flujo de caja
148.57

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
926
NUVL
Nuvalent, Inc. - Class A Common Stock
123.96 USD0.00%+0.18%+0.45%+30.55%9.79 B USD
941
CORT
Corcept Therapeutics Incorporated - Common Stock
88.61 USD-2.06%-5.99%+6.53%+20.77%9.51 B USD
979
PRAX
Praxis Precision Medicines, Inc. - Common Stock
320.81 USD-2.10%+0.86%+21.09%+515.99%8.94 B USD
983
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
53.78 USD-2.09%-37.02%-27.26%-25.44%8.89 B USD

Noticias